Bayer, Janssen Sue Taro Over Xarelto Generic
Pharmaceutical companies Bayer and Janssen have accused rival Taro of infringing a patent covering a drug that prevents major cardiovascular events, expanding a fight over whether Taro's generic version would violate...To view the full article, register now.
Already a subscriber? Click here to view full article